| 723908 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer |
2021-08-01 |
10.1136/jitc-2021-002467 |
Zeng Dongqiang, Wu Jiani, Luo Huiyan, Li Yong, Xiao Jian, Peng Jianjun, Ye Zilan, Zhou Rui, Yu Yunfang, Wang Gaofeng, Huang Na, Wu Jianhua, Rong Xiaoxiang, Sun Li, Sun Huiying, Qiu Wenjun, Xue Yichen, Bin Jianping, Liao Yulin, Li Nailin, Shi Min, Kim Kyoung-Mee, Liao Wangjun |
| 723907 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids |
2021-08-01 |
10.1136/jitc-2021-003000 |
Hamdan Firas, Ylösmäki Erkko, Chiaro Jacopo, Giannoula Yvonne, Long Maeve, Fusciello Manlio, Feola Sara, Martins Beatriz, Feodoroff Michaela, Antignani Gabriella, Russo Salvatore, Kari Otto, Lee Moon, Järvinen Petrus, Nisen Harry, Kreutzman Anna, Leusen Jeanette, Mustjoki Satu, McWilliams Thomas G, Grönholm Mikaela, Cerullo Vincenzo |
| 723906 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial |
2021-08-01 |
10.1136/jitc-2021-002568corr1 |
|
| 723905 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer |
2021-08-01 |
10.1136/jitc-2021-002891 |
Negrao Marcelo V, Skoulidis Ferdinandos, Montesion Meagan, Schulze Katja, Bara Ilze, Shen Vincent, Xu Hao, Hu Sylvia, Sui Dawen, Elamin Yasir Y, Le Xiuning, Goldberg Michael E, Murugesan Karthikeyan, Wu Chang-Jiun, Zhang Jianhua, Barreto David S, Robichaux Jacqulyne P, Reuben Alexandre, Cascone Tina, Gay Carl M, Mitchell Kyle G, Hong Lingzhi, Rinsurongkawong Waree, Roth Jack A, Swisher Stephen G, Lee Jack, Tsao Anne, Papadimitrakopoulou Vassiliki, Gibbons Don L, Glisson Bonnie S, Singal Gaurav, Miller Vincent A, Alexander Brian, Frampton Garrett, Albacker Lee A, Shames David, Zhang Jianjun, Heymach John V |
| 723904 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T |
2021-08-01 |
10.1136/jitc-2021-002931 |
Dorff Tanya, Hirasawa Yosuke, Acoba Jared, Pagano Ian, Tamura David, Pal Sumanta, Zhang Minlu, Waitz Rebecca, Dhal Abhilash, Haynes Winston, Shon John, Scholz Mark, Furuya Hideki, Chan Owen T M, Huang Jeffrey, Rosser Charles |
| 723903 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8+T cells and promoting fatty acid metabolism |
2021-08-01 |
10.1136/jitc-2021-003093 |
Sun Pu, Zhang Xi, Wang Rong-Jing, Ma Qing-Yang, Xu Lan, Wang Yi, Liao Hui-Ping, Wang Hai-Long, Hu Lan-Dian, Kong Xiangyin, Ding Jian, Meng Ling-Hua |
| 723902 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia |
2021-08-01 |
10.1136/jitc-2021-002332 |
Choi Jeong Uk, Lee Na Kyeong, Seo Hyungseok, Chung Seung Woo, Al-Hilal Taslim A, Park Seong Jin, Kweon Seho, Min Nuri, Kim Sang Kyoon, Ahn Seohyun, Kim Uk-Il, Park Jin Woo, Kang Chang-Yuil, Kim In-San, Kim Sang Yoon, Kim Kyungjin, Byun Youngro |
| 723901 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Mesenchymal stem cells and oncolytic viruses: joining forces against cancer |
2021-08-01 |
10.1136/jitc-2020-001684corr1 |
|
| 723900 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege |
2021-08-01 |
10.1136/jitc-2021-003246 |
Ager Casey R, Boda Akash, Rajapakshe Kimal, Lea Spencer Thomas, Di Francesco Maria Emilia, Jayaprakash Priyamvada, Slay Ravaen B, Morrow Brittany, Prasad Rishika, Dean Meghan A, Duffy Colm R, Coarfa Cristian, Jones Philip, Curran Michael A |
| 723899 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer |
2021-08-01 |
10.1136/jitc-2020-001498corr1 |
|
